Kenvue Inc (NYSE:KVUE)
$ 23.39 0.31 (1.34%) Market Cap: 44.80 Bil Enterprise Value: 51.79 Bil PE Ratio: 40.33 PB Ratio: 4.40 GF Score: 27/100

Q2 2024 Kenvue Inc Earnings Call Transcript

Aug 06, 2024 / 12:30PM GMT
Release Date Price: $20.86 (+14.68%)

Key Points

Positve
  • Kenvue Inc (KVUE) achieved year-over-year organic growth of 1.5% on top of 7.7% organic growth last year.
  • Adjusted gross profit margin increased by 410 basis points to 61.6%.
  • The company is on track to deliver its financial goals for 2024, including an expected 150 basis points of adjusted gross profit margin expansion.
  • Significant progress in productivity and cost reduction efforts, providing strategic flexibility.
  • Increased investment in brands by approximately 20% compared to last year, focusing on high-yield strategies.
Negative
  • Skin health and beauty segment saw a 2.4% decline in organic growth year-over-year.
  • Volume was down 0.6% year-over-year, with low single-digit volume declines in both self-care and skin health and beauty segments.
  • The company incurred a non-cash after-tax charge of $337 million due to impairment of assets related to the Dr.Ci:Labo business.
  • Retail destocking in the US impacted the first half of the year.
  • The company expects lower gross margins in the back half of the year due to annual plant maintenance and lower commodity inflation benefits.
Operator

Hello, and welcome to the Kenvue second quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jim Giannakouros, Interim Head of Investor Relations for Kenvue.

Jim Giannakouros
Kenvue Inc - Investor Relations

Good morning, everyone, and welcome to Kenvue's second quarter 2024 earnings conference call. I'm pleased to be joined today by Thibaut Mongon, Kenvue's Chief Executive Officer; and Paul Ruh, our Chief Financial Officer.

Before we get started, I'd like to remind you that today's call includes forward-looking statements regarding, among other things, our operating and financial performance, market opportunities and growth. These statements represent our current beliefs or expectations about future events and are subject to various risks, uncertainties, and assumptions that could cause our actual results to differ materially.

For information regarding these risks and uncertainties, please refer to our earnings materials related to this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot